Sourasky Medical Center (Ichilov)
Bookimedは慢性腎臓病治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。慢性腎臓病治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。慢性腎臓病治療の旅路でお一人になることはありません。
Dr. Barak Rosenzweig, MD, directs the Urological Oncology Service at Sheba Medical Center. He is a uro-oncologic surgeon with nearly 20 years of experience. He treats complex urologic cancers with advanced robotic and minimally invasive methods. He is listed among Israel’s Best Doctors by Forbes.
Expertise includes tumors of the prostate, kidney, bladder, testis, and upper urinary tract. He performs robotic radical prostatectomy, kidney-sparing partial nephrectomy, and advanced laparoscopy. Diagnostics include MRI-guided fusion biopsy and imaging-based personalized planning.
He completed a Urological Oncology fellowship at Memorial Sloan Kettering Cancer Center. He is a Senior Physician in the Department of Urology and a Clinical Senior Lecturer at Tel Aviv University. He is a graduate of the Sheba Talpiot program. He is an active researcher with over 200 publications in urologic oncology.
Dr. Pazit Beckerman is a nephrologist with over 24 years of clinical practice in Israel. She specializes in chronic kidney disease (CKD), acute kidney injury (AKI), hemodialysis and peritoneal dialysis, hypertension-related kidney disease, glomerular diseases and proteinuria, electrolyte disorders, and kidney involvement in systemic diseases.
She served as Acting Director in 2020, Deputy Director from 2018 to 2020, and Senior Physician in the Department of Nephrology at Sheba Medical Center. She also heads the Israeli Dialysis Registry.
Education and training: MD, Hebrew University–Hadassah. Nephrology residency, Hadassah. Fellowship in nephrology, Sheba Medical Center. Biomedical Computational Studies, Bar-Ilan University. Postdoctoral fellowship, University of Pennsylvania.
Her research focuses on AKI, immune-related kidney complications, and chronic kidney disease. She has authored many publications. She is a member of the American Society of Nephrology and a board member of the Israeli Society of Nephrology and Hypertension.
Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.
He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.
His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.
He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.
Israeli hospitals assess chronic kidney disease severity using glomerular filtration rate calculations and urinary albumin-to-creatinine ratios. Advanced protocols integrate next-generation exome sequencing for genetic mapping. Nuclear imaging and superb microvascular imaging provide precision mapping of functional renal mass and tissue fibrosis.
Bookimed Expert Insight: Israeli nephrology stands out through its leadership in specialized registries. Dr. Pazit Beckerman at Sheba Medical Center directs the Israeli Dialysis Registry. This high-level data integration allows clinicians to predict progression trends across 240 specialized departments. Such oversight ensures that diagnostic protocols align with real-world outcomes for systemic kidney involvement.
Patient Consensus: Patients emphasize tracking trends in glomerular filtration and protein levels through dedicated apps between visits. Many suggest requesting a full panel of blood, urine, and ultrasound tests at every consultation.
Israel utilizes regenerative medicine, non-invasive acoustic therapies, and minimally invasive procedures to delay dialysis. Key treatments include autologous cell therapy to rejuvenate tissue and shockwave devices that stimulate blood vessel growth. Specialist centers integrate these with advanced hypertension management to preserve remaining kidney function.
Bookimed Expert Insight: Israeli nephrology stands out because top specialists like Dr. Pazit Beckerman at Sheba Medical Center hold leadership roles in national dialysis registries. This direct oversight of long-term outcomes drives the early adoption of preventive protocols. While many focus on experimental cells, the integration of 20+ years of clinical expertise with specialized endourology, such as the kidney-sparing laser techniques pioneered by Dr. Nir Kleinmann, offers a more immediate way to protect existing organ health before failure occurs.
Patient Consensus: Patients emphasize that early aggressive management with medications like SGLT2 inhibitors and ketoanalog supplements often provides more stability than waiting for experimental options. Many travelers feel relieved by the high level of monitoring, noting that keeping blood pressure under 120 through daily tracking is vital for their eGFR levels.
International patients can receive a kidney transplant in Israel only through living-donor transplants from first-degree relatives. Non-residents are legally prohibited from receiving organs from deceased donors under the 2008 Organ Transplantation Law. Every case requires approval from the Israeli Ministry of Health.
Bookimed Expert Insight: Israeli medical centers like Sourasky (Ichilov) handle massive patient volumes, treating up to 1,800,000 people annually. This high operational capacity means transplant teams are exceptionally practiced, though the legal barrier remains strict. Specialists like Dr. Pazit Beckerman have over 20+ years of experience in nephrology, ensuring high-level pre-surgical management.
Patient Consensus: Patients note that Israeli citizenship or strong family ties are virtually mandatory for approval. Many suggest exploring living donor options early as unrelated donors from abroad are rarely approved.
End-stage renal disease patients in Israel primarily use in-center hemodialysis, serving 92% of the maintenance population. Options include home peritoneal dialysis and limited home hemodialysis. Care is delivered through JCI-accredited hospitals like Sourasky Medical Center and community clinics using advanced high-flux filtration technologies.
Bookimed Expert Insight: While hemodialysis is the standard, Israel's infrastructure uniquely prioritizes security. Many community and hospital units are bomb-reinforced. This ensures that even during security events, life-sustaining treatments continue without interruption. Patients should verify if their assigned clinic has these specific safety certifications during the intake process.
Patient Consensus: Patients often recommend starting with in-center sessions for professional monitoring. However, many note that switching to home-based peritoneal dialysis significantly improves daily energy and scheduling freedom if hygiene protocols are strictly followed.
Israeli nephrology centers provide multidisciplinary care integrating Mediterranean-Renal diets, digital tracking, and lifestyle coaching. Specialist teams at facilities like Sheba Medical Center and Sourasky Medical Center focus on stage-dependent protein regulation. This proactive approach aims to stabilize kidney function and delay the need for dialysis.
Bookimed Expert Insight: Israeli nephrologists like Dr. Pazit Beckerman often use computational studies and registries to refine patient care. Our data shows that top doctors in Israel prioritize research-backed methods like the OLYMPUS trial for kidney diseases. Patients benefit from this academic depth, as it leads to more precise adjustments in metabolic and electrolyte management compared to standard protocols.
Patient Consensus: Patients value how centers emphasize renal superfoods like cauliflower and apples rather than just restricting favorites. Many note that learning to space protein intake evenly serves as a crucial tool for preventing kidney damage spikes.